CVRx (United States)

company in Minneapolis, United States

CVRX Nasdaq SEC CIK 1235912
Follow CVRx (United States) Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $13.8M −5.8% vs same quarter last year
Net income −$14.2M −10% vs same quarter last year
EPS, diluted −$0.52 −6.1% vs same quarter last year
Operating cash flow −$10.9M −12.2% vs same quarter last year
Revenue by quarter
$15.3M
$12.3M
$13.6M
$14.7M
$16M
$14.8M
$15.7M
$13.8M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−$100M−$50M$0$50M$100MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$56.7M−$53.3M
FY24$51.3M−$60M
FY23$39.3M−$41.2M
FY22$22.5M−$41.4M
FY21$13M−$43.1M
FY20$6.1M−$14.1M
FY19--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−400%−200%0%200%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2585.3%−90.5%−94.1%
FY2483.8%−116%−116.9%
FY2384.1%−109.7%−104.8%
FY2277.8%−189.3%−184.4%
FY2172.1%−199.2%−330.5%
FY2076.2%−190.2%−233.1%
FY19---
Free cash flowOperating cash flow minus capital expenditure
−$60M−$40M−$20M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$40.8M
FY24−$40.5M
FY23−$39.6M
FY22−$43.4M
FY21−$28.9M
FY20−$16.4M
FY19-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • CVRx (United States)
  • Healthcare median
−400%−300%−200%−100%0%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearCVRx (United States)Healthcare median
FY25−94.1%−30.6%
FY24−116.9%−47%
FY23−104.8%−58%
FY22−184.4%−80.4%
FY21−330.5%−71.8%
FY20−233.1%−62.2%
FY19-−46.2%